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Background: Hypoxia following traumatic brain injury (TBI) is a severe insult shown to 
exacerbate the pathophysiology, resulting in worse outcome. The aim of this study was 
to investigate the effects of a hypoxic insult in a focal TBI model by monitoring brain 
edema, lesion volume, serum biomarker levels, immune cell infiltration, as well as the 
expression of hypoxia-inducible factor-1 alpha (HIF-1α) and vascular endothelial growth 
factor (VEGF).
Materials and methods: Female Sprague-Dawley rats (n = 73, including sham and 
naive) were used. The rats were intubated and mechanically ventilated. A controlled 
cortical impact device created a 3-mm deep lesion in the right parietal hemisphere. 
Post-injury, rats inhaled either normoxic (22% O2) or hypoxic (11% O2) mixtures for 
30 min. The rats were sacrificed at 1, 3, 7, 14, and 28 days post-injury. Serum was 
collected for S100B measurements using ELISA. Ex vivo magnetic resonance imaging 
(MRI) was performed to determine lesion size and edema volume. Immunofluorescence 
was employed to analyze neuronal death, changes in cerebral macrophage- and neu-
trophil infiltration, microglia proliferation, apoptosis, complement activation (C5b9), IgG 
extravasation, HIF-1α, and VEGF.
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inTrODUcTiOn
Traumatic brain injury (TBI) is the leading cause of death and 
disability among young adults worldwide and is constantly 
increasing among the elderly (1–3). TBI consists of two processes: 
the initial traumatic impact at the accident scene causing primary 
damage to the cerebral parenchyma and blood vessels, followed 
by the onset of detrimental secondary insults (4), subsequently 
resulting in progressive cerebral deterioration (5). These insults 
include intracranial hypertension, hypoxia, hypotension, 
metabolic dysfunction, and seizures and may lead to irreversible 
delayed injuries that impair functional recovery after TBI (5, 6). 
Unconscious patients suffering from TBI are treated at specialized 
neuro-intensive care units where the goal is to detect and treat 
secondary insults to optimize cerebral recovery. Neuroradiology 
is used to detect intracranial pathology, magnetic resonance 
imaging (MRI) being superior to computerized tomography (CT) 
in revealing edema and ischemia after TBI (7).
A decreased level of oxygen saturation in the brain, defined 
as cerebral hypoxia, may be the result of obstructed airways, res-
piratory failure or any other injuries to lungs, chest, or associated 
vessels. Epidemiological studies have shown that 20–45% of TBI 
patients suffer from pre-hospital hypoxia (6, 8), a condition that 
has been correlated to worse outcome (6, 9–11). Reduced cerebral 
oxygenation may contribute to ischemic damage, an irreversible 
secondary brain injury that is frequently seen in autopsy materials 
of TBI patients (12). In experimental TBI, the addition of hypoxia 
causes an exacerbated cerebral inflammatory response (13, 14), 
aggravated neuronal death, and larger lesion size (14–17), having 
a profound effect on blood–brain barrier (BBB) dysfunction, 
edema formation (13, 18, 19), and increased intracranial pressure 
(20), as well as worse functional outcomes (13, 14, 19, 21–23). 
The pathophysiological impact of hypoxic insult after TBI is not 
fully understood. Post-traumatic hypoxia is thought to trigger 
a cascade of events, leading to apoptosis and tissue loss (24). 
A transient hypoxic state will aggravate the physiological disarray 
in the perilesional area, challenging the metabolic demand and 
energy supply for cells already in a critical state.
The inflammatory response following TBI has been shown 
to possess both detrimental and beneficial properties (25). This 
involves the activation of the innate immune system, leading to 
cerebral accumulation of peripheral macrophages and leukocytes 
as well as the mobilization of local microglia around the lesion 
occurring mainly during the first week following TBI (26). The 
complement system, a key element of the innate immune system, 
regulating the chemotaxis and lysis of cells, has also been shown 
to increase in activity specifically in brain regions adjacent to 
traumatic contusions in both rats (27) and humans (28).
Hypoxia-inducible factor-1 alpha (HIF-1α), a transcription 
factor involved in oxygen homeostasis (29), provides an adap-
tive response to the pathological conditions occurring during 
hypoxia (30). When oxygen concentration drops, HIF-1α 
triggers the upregulation of several genes, which may result in 
either detrimental cellular pathways such as apoptosis (31), or 
neuro-protective effects including angiogenesis through the 
upregulation of vascular endothelial growth factor (VEGF) (32), 
erythropoiesis via the induction of erythropoietin (33, 34) as well 
as mitochondrial integrity (35) and cell survival (36).
S100B, a protein present primarily in perivascular astrocytes 
(37), is measured in blood early after TBI and used as a reliable 
biomarker to detect and grade the severity (38) of brain damage 
in clinical practice (39). High levels of S100B have been correlated 
to an unfavorable outcome (40) while its delayed elevation has 
been associated primarily with the development of secondary 
ischemia (41, 42).
Although numerous studies have addressed the pathological 
consequences of post-traumatic hypoxia in models of TBI (18, 
19, 21, 43–45), several aspects aggravated by this insult remain 
obscure. The main focus of hypoxic TBI models has been primar-
ily to assess changes in neuronal loss (22, 46), with only a few 
results: The hypoxic group had significantly increased blood levels of lactate and 
decreased pO2 (p < 0.0001). On MRI post-traumatic hypoxia resulted in larger lesion 
areas (p =  0.0173), and NeuN staining revealed greater neuronal loss (p =  0.0253). 
HIF-1α and VEGF expression was significantly increased in normoxic but not in hypoxic 
animals (p < 0.05). A trend was seen for serum levels of S100B to be higher in the hypoxic 
group at 1 day after trauma (p = 0.0868). No differences were observed between the 
groups in cytotoxic and vascular edema, IgG extravasation, neutrophils and macrophage 
aggregation, microglia proliferation, or C5b-9 expression.
conclusion: Hypoxia following focal TBI exacerbated the lesion size and neuronal loss. 
Moreover, there was a tendency to higher levels of S100B in the hypoxic group early 
after injury, indicating a potential validity as a biomarker of injury severity. In the normoxic 
group, the expression of HIF-1α and VEGF was found elevated, possibly indicative of 
neuro-protective responses occurring in this less severely injured group. Further studies 
are warranted to better define the pathophysiology of post-TBI hypoxia.
Keywords: traumatic brain injury, hypoxia, hypoxia-inducible factor 1, vascular endothelial growth factor a, 
s100B, edema, neuronal death, secondary insults
FigUre 1 | cytotoxic and vasogenic edema following injury. Left picture depicts the area of decreased apparent diffusion coefficient (ADC) indicating cytotoxic 
edema (1 day hypoxic). Right picture shows the area affected by an increase in ADC highlighting vasogenic edema (14 days normoxic). The freehand tool in ImageJ 
was used to define the areas (yellow).
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studies analyzing the underlying pathophysiological mechanisms 
(13, 14). The neuro-inflammatory response has been studied in 
diffuse hypoxic TBI (14), but to the best of our knowledge not in 
a focal hypoxic TBI model. In addition, complement activation, 
S100B monitoring, and HIF-1α and VEGF expression have never 
before been examined in hypoxic-TBI. Moreover, while the MRI 
technique has been utilized acutely after TBI (19, 47), extensive 
follow-up 4 weeks has never been performed.
By using an animal model of focal (controlled cortical impact, 
CCI) hypoxic TBI, we expect to better elucidate the burden of 
the secondary hypoxic insult by providing in-depth changes in 
radiological, histological, metabolic, inflammatory, and serum 
markers of injury.
aims
The primary aim of our study was to employ a hypoxic focal TBI 
rat model using the CCI paradigm and to explore the effect of 
post-traumatic hypoxia on brain morphological changes includ-
ing lesion progression and vascular/cytotoxic edema, serum 
profiles of the biomarker S100B, alteration of metabolic param-
eters (lactate), brain histopathological features such as neuronal 
survival, leukocyte and macrophage infiltration, all of which were 
compared to normoxic rats, over 4 weeks.
MaTerials anD MeThODs
animals
All procedures were conducted following approval by the ethical 
committee of the Swedish Board of Agriculture (applications 
#N369/12 and #N126/13). Seventy-three female Sprague-Dawley 
rats were included. On the day of surgery rats weighed an average 
251 g (~15 weeks of age). Animal were housed in a 12-h light/dark 
cycle with food and water ad  libitum and kept throughout the 
study at room temperature (21 ± 1°C) with normal air humidity.
anesthesia and Oxygen 
Monitoring – set Up
The animals were anesthetized using a mixture of 5% isoflurane 
in  22% O2/78% N2, then intubated using the plastic tubing of 
a 16 gage angiocatheter (KD Medical, Berlin, Germany), and 
 mechanically ventilated (Rodent ventilator, Ugo Basile, Gemonio, 
Italy) with a maintenance dose of 2–3% isoflurane in 22% O2/78% 
N2. A re-built pediatric gas mixer with vaporizer was used (Dameca 
A/S, currently Philips Electronics, Amsterdam, Netherlands and 
Penlon, Oxford, UK). A pulsoximetry device was attached to the 
rat’s right back paw to monitor heart rate and oxygen saturation 
(MouseSTAT™, Kent Scientific, Torrington, CT, USA). In order 
to certify that a correct amount of oxygen was inhaled, a portable 
oxygen analyzer was used (TED 60-T, Teledyne Electronic Devices, 
Thousand Oaks, CA, USA). The respiratory rate was kept 90 bpm 
and the tidal volume to 2 mL, according to normal levels in an 
anesthetized spontaneously breathing rat (48). The anesthesiology 
set-up is illustrated in Figure S1 in Supplementary Material.
surgery – Procedure
Following adequate sedation, local anesthesia [0.15 mL of bupi-
vacaine (Marcaine®) 0.25%] was injected subcutaneously in the 
scalp above the cranial midline, while buprenorphine (Temgesic®) 
(0.05 mg/kg) and carprofen (5 mg/kg) were injected subcutane-
ously in the abdominal region, in order to provide  analgesia. 
Eye-gel [containing fusidic acid (Fucithalmic®)] was applied to 
protect the eyes, and isotonic saline (NaCl 9 mg/mL) was used 
to rinse and clean the scalp wound throughout the experiment. 
Following pre-medications, the rat was placed on a heating 
pad (Temperature Control Unit HB 101/2, Panlab, Harvard 
Apparatus, Barcelona, Spain) attached to a stereotaxic frame 
(Model 900, Agnthos, Stockholm, Sweden). During the surgical 
procedure, the rats’ body temperature was maintained within a 
normal range (average 37.2°C) (49).
Using a surgical drill with a diamond tip of 0.5 mm diameter 
(Microspeed 317 IN; Silfradent, Forli, Italy), a portion of the 
parietal bone over the right hemisphere was removed, at 3.5 mm 
right of the central suture and 4.5 mm posterior to lambda. For 
precision, the procedure was performed under a surgical micro-
scope (Wild Heerbrugg M3C Stereozoom Microscope, Leica, 
Wetzlar, Germany). A piston of 3 mm in diameter was used to 
impact a 3-mm deep lesion in the right parietal lobe, producing 
an injury previously defined as a “severe TBI” (50) (Figure 1). 
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A commercially available CCI device was employed (TBI 0310, 
Precision Systems and Instrumentation LLC, Lexington, KY, 
USA), as described in previous studies (51, 52). The lesion 
produced mimics the conditions seen in the clinical setting of a 
focal TBI (53). The wound was sutured using Vicryl 4-0 (Ethicon, 
Johnson & Johnson, New Brunswick, NJ, USA).
Following trauma, the animals were ventilated with either a 
hypoxic (11% O2/88% N2) (AGA AB, Linde, Munich, Germany) 
or normoxic (22% O2/78% N2) gas mixture for 30 min, with an 
appropriate amount of isoflurane to maintain sedation (1–1.5%). 
This protocol has previously been shown to induce a systemic 
hypoxia, resulting in an oxygen saturation of 47 ± 4.3% and pO2 
of 48.5 ± 3.8 mmHg (6.47 ± 0.5 kPa), and a brief hypotensive 
episode, with mean arterial pressure (MAP) dropping to 
69.5 ± 29.5 mmHg after 15 min (21, 22). A previous study, by a 
member of our group, has determined that partial oxygen pres-
sure, oxygen saturation, and blood pressure normalize 15  min 
after the completion of the hypoxic phase (14). Our set-up was 
similar to a hypoxic TBI model of diffuse injury used by the 
collaborating group (13), though now applied to a CCI model 
generating a focal, severe injury.
Following 30  min of hypoxia/normoxia, the animals were 
placed on a heat pad until fully awake (~30 min) before return-
ing to their home cages. The mortality rate for the experiment 
was about 20% during trauma/hypoxia induction, and no deaths 
occurred post-surgery.
In sham animals, all procedures including craniotomy, apart 
from the impact, were conducted. This included a position cali-
bration performed before every impact by the impactor, applying 
~0.6 g of weight to the dura before the impact (as default by the 
manufacturer).
A video demonstrating the surgical and post-operative proce-
dure is provided in Video S1 in Supplementary Material.
Preoperative Monitoring
The MouseSTAT device (Kent Scientific, Torrington, CT, USA) 
attached to the rat’s back right paw was used to monitor physi-
ological parameters throughout the experimental procedure, 
including pulse, saturation, and perfusion index. According 
to the manufacturer, perfusion index is a value indicating the 
strength of the plethysmographic signal at the sensor site. The 
greater the number, the greater the level of blood flow is at the 
sensor site. Data were recorded for the whole experimental 
procedure as well as during the 30 min of normoxic or hypoxic 
ventilation.
arterial Blood sampling
Following the normoxic/hypoxic period, a small incision was 
performed along the midline of the tail base to expose the artery. 
A heparin-coated blood gas syringe was inserted, and about 
2 mL of blood was drawn and immediately used for blood gas 
analysis (ABL800 FLEX analyzer, Radiometer Medical, Brønshøj, 
Denmark). The wound was readily stitched using Vicryl 4-0.
euthanasia and experimental groups
Traumatic brain injury rats were divided into two groups: 
a group (n =  25) subjected to a normoxic gas mixture and a 
second group (n = 25) exposed to the hypoxic gas mixture. Rats 
of both groups were euthanized at 1, 3, 7, 14, and 28 days fol-
lowing injury (n = 5 per day) using an 80 mg/kg intraperitoneal 
pentobarbital injection. For control, we included normoxic 
(n = 10) and hypoxic (n = 10) sham rats (day 1 and 7 post-injury, 
n = 5 per group) and naive rats (n = 3), resulting in a total of 
n = 73 rats.
Blood collection and isolation of serum
After the animal received a lethal dose of pentobarbital, the heart 
was punctured using an angiocatheter (18G, KD Medical, Berlin, 
Germany) and blood was collected in two test tubes (2 × 1.5 mL 
test tube, 3810X, Eppendorf, Hamburg, Germany). The tubes 
were placed vertically for about 1  h to allow fractionation. 
Afterward, the blood was centrifuged (Spectrafuge16M®, Labnet 
International, Edison, NJ, USA) for 10 min at 10,000 × g [about 
11,000 rotations per minute (RPM)], the serum was collected, 
and the frozen in −80°C.
s100B Measurement and analysis
A commercially available S100B ELISA kit was used (CanAg 
EIA S100, Fujirebio Diagnostics AB, Göteborg, Sweden). Serum 
samples where thawed overnight at 4°C and were transferred 
(50 μL per well) to a pre-coated 96-well plate (in duplicates) 
and run according to manufacturer’s protocol. The results 
were analyzed using a Multiskan EX and Ascent Software V2.6 
(ThermoLabSystems, Thermo Scientific, Waltham, MA, USA). 
Absorbance was measured at 620 nm, and cubic spline curve 
fit method was used to fit the absorbance as recommended 
by the manufacturer. Extrapolation was used for sample levels 
outside the calibration reference levels. Outliers (deviating 
more than 5 SD) were excluded (n = 2) (both normoxic, day 7), 
as well as animals with an inadequate sample volume (n = 1) 
(hypoxic, day 7).
Ex Vivo Magnetic resonance imaging
Following euthanasia, ex vivo MRI scanning was performed on two 
animals from each time point per group (normoxia and hypoxia 
on days 1, 3, 7, 14, 28, and sham on day 1). A total of 23 rats were 
scanned (one hypoxic brain on day 28 could not be used due to 
procedural errors). Each brain was fixed in formalin (as described 
in Section “Brain Preparation for Immunofluorescence”) and 
positioned in a syringe filled with Fomblin (Solvay Solexis, 
Brussels, Belgium) to avoid image artifacts due to susceptibility 
mismatch while providing a dark background. A horizontal 9.4-T 
magnetic resonance scanner (Agilent, Yarnton, UK) equipped 
with a millipede coil of 30-mm inner diameter coil was used 
for data acquisition. The brains were scanned overnight using 
a diffusion-weighted spin echo with gradients applied in 30 dif-
ferent directions as well as a reference image with the diffusion 
encoding gradients set to 0 (tr = 2.5 s, te = 20.83 ms, nex = 2, 
matrix = 192 × 192, FOV = 19.2 mm × 19.2 mm, 51 continuous 
0.5 mm thick slices). The data were zero-filled to 256 × 256 points 
before Fourier transformation. The diffusion-weighted data were 
interpreted using the diffusion tensor model. The T2-weighted 
reference image, the fractional anisotropy map, and the diffusion-
weighted image were analyzed further as described below.
TaBle 1 | Primary and secondary antibodies.
antibody Manufacturer Product-iD Dilution secondary exposure 
time
cut-off
DAPI Life Technologies P36931 NA (Included in mounting medium) 0.08 NA
NeuN Millipore ABN90 1:8000 Cy3, anti-guinea pig, 706-165-148, Jackson  
Laboratories, 1:200
0.12 NA
ED1 (CD68) Serotec MCA341R 1:2000 Cy5, anti-mouse, 715-175-150, Jackson Laboratories, 1:200 0.24 10
Activated Caspase 3 Abcam AB2302 1:300 Cy2, anti-rabbit, 711-545-152, Jackson Laboratories, 1:200 0.24 22
C5b-9 Dako M0777 1:500 Cy5 (anti-mouse)a 0.08 100
Leukosialin (CD43, 
W3/13)
Serotec MCA54 1:250 Cy5, anti-mouse, 715-175-150, Jackson Laboratories, 1:200 0.28 36
VEGF-Alpha Antibodies online AA-27190/
ABIN1078647
1:250 Cy5, anti-mouse, 715-175-150, Jackson Laboratories, 1:200 0.28 24
IgG Antibodies online ABIN458741 1:500 Cy3.5, anti-goat, 705-585-147, Jackson Laboratories, 1:200 0.20 90
HIF-1α Millipore MAB5382 1:250 Cy5, anti-mouse, 715-175-150, Jackson Laboratories, 1:200 0.22 31
CD34 Antibodies online ABIN1719820 1:250 Cy2, anti-rabbit, 711-545-152, Jackson Laboratories, 1:200 0.32 90
Primary and secondary antibodies used in immunofluorescence labeling. Exposure time indicates the “integration time” for the microscope to scan each section of the slide. “Cut-
off” is the threshold used in ImageJ, antibody expression above this level was quantified. For C5b-9, tyramide signal amplification was used (see Tyramide Signal Amplification for 
Detection of Complement Factor C5b-9).
aWas used together with tyramide signal amplification.
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Mri – lesion area Measurement
The software ImageJ® (1.48v, NIH, Bethesda, MD, USA) was used 
to map the lesion area using the “Polygon selections.” T2 images 
were taken at 7, 14, and 28 days post-TBI since they had well-
defined lesion areas. All sections with a lesion were assessed and 
the largest lesion area per brain was chosen for quantification.
Mri – edema Quantification
The freehand tool in ImageJ was used to detect the pericontu-
sional area with an increased apparent diffusion coefficient 
(ADC) signaling indicating vasogenic edema and a decreased 
ADC indicating cytotoxic edema (54–56) (Figure  1). All MRI 
sections including edema were quantified and displayed as max 
value (square millimeter) per animal. The lesion cavity was not 
included in the edema areas.
Brain Preparation for immunofluorescence
After euthanasia, transcardial perfusion was performed using 
300 mL NaCl (9 mg/mL) (37°C) followed by a perfusion-fixation 
over 10 min with 300 mL chilled paraformaldehyde (PFA) (4°C) 
(P6148, 4%, Sigma-Aldrich, Germany). The rat was finally decapi-
tated and the brain immerged in a 4% formaldehyde solution for 
1 h. Following a rinse step, the brain was stored in a PBS Mill 
solution (in house) containing 0.1% NaN3 (sodium azide). Prior 
to sectioning, the brain was immerged in 30% sucrose solution 
for 3 days and then immediately frozen to −80°C. Using a cryostat 
(Cryostar NX70, ThermoScientific, Waltham, MA, USA) brains 
were cut in coronal sections of 14 μm thickness and placed on 
Superfrost® glass slides. The sections included the whole lesion 
(n = 100 slides per brain with two to three sections per slide). 
Subsequently, the tissue was air-dried and then frozen at −20°C.
immunofluorescence – antibodies
Commercially available primary and secondary antibodies were 
used as presented in Table 1. To best visualize the immune cell 
activation to cerebral injury, we chose the following antibodies: 
CD68/ED1 for macrophages (and activated microglia) (14, 57); 
CD34 for proliferating microglia (58) and CD43/W3/13 for neu-
trophils; Activated caspase 3 antibody for cell apoptosis (59); and 
NeuN (Neuronal Nuclei/Fox3) for neurons. In addition, we used 
a specific antibody against the membrane attack complex (C5b-9) 
for detection of end stage activation of the complement cascade 
(28), anti-HIF-1α antibody to monitor changes in this transcrip-
tion factor (60) as well as an antibody against VEGF alpha to detect 
increased angiogenesis (61) and anti-rat IgG to quantify the extent 
of BBB disruption (18). DAPI (4′,6- diamidino-2-phenylindole) 
was chosen as cellular counterstain. For control, all secondary 
antibodies were tested with omission of the primary antibod-
ies resulting in no significant background noise, as seen in 
Figures S2A–D in Supplementary Material.
immunofluorescence – staining Protocol
When preparing for immunofluorescence, all slides were air-
dried at room temperature and then rehydrated in phosphate 
buffered saline (PBS) (P4417 Sigma-Aldrich, St. Louis, MO, USA) 
for 15 min. Primary antibodies were diluted in 0.3% Triton X-100 
(X100, Sigma-Aldrich, St. Louis, MO, USA) and 0.1% NaN3 in 
PBS pH7.4 for 16 h (4°C). Afterwards, sections were washed three 
times in Tris Buffered Saline solution, with Tween® 20 (0.05%) 
(TBS-Tween 20, T9039 Sigma-Aldrich, St. Louis, MO, USA) for 
15  min. The sections were blocked with a Tris–NaCl-blocking 
buffer (TNB-buffer, FP1020, PerkinElmer, Waltham, MA, USA) 
for 30 min at room temperature. This was followed by the addi-
tion of the secondary fluorescent labeled antibody mix diluted in 
TNB-buffer and sections incubated for 90 min at room tempera-
ture. Subsequently, the sections were washed three times in 0.05% 
TBS-Tween 20 for 15 min, in the dark. The sections then were 
immersed in 70% EtOH for 5  min before being transferred to 
Sudan Black (1% solution, 70%EtOH) for 10 min and then rinsed 
in 70% EtOH for about a minute before being mounted, using 
PVA/DABCO (ProLong® Gold anti-fade with DAPI, P36931, 
Life Technologies, Thermo Fisher Scientific, Waltham, MA, USA) 
FigUre 2 | Detection of expression. A person blinded for oxygenation 
state and survival time highlighted the region of interest surrounding the 
lesion (yellow circle). The protein expression, above a specific threshold, was 
then used to quantify the expression. In this case, the expression of C5b-9 
(white) is shown in a hypoxic animal, at 1 day following CCI.
March 2016 | Volume 7 | Article 236
Thelin et al. Post-TBI Hypoxia Exacerbates Neuronal Death
Frontiers in Neurology | www.frontiersin.org
and then stored at −20°C until analysis. For immunofluorescence 
experiments, we used all normoxic (n = 25) and hypoxic animals 
(n = 25).
Tyramide signal amplification for 
Detection of complement Factor c5b-9
Due to the low signals using the C5b-9 direct immunofluores-
cence protocols, a tyramide signal amplification (TSA) proce-
dure was employed. The TSA method is based on horseradish 
peroxidase (HRP)-conjugated secondary antibodies followed by 
incubation with a biotinyl tyramide-cyanine 5 conjugate (Perkin-
Elmer, Waltham, MA, USA) diluted 1:150 in amplification buffer 
for 15  min at room temperature. Lastly, sections were washed 
three times for 15 min each in TBS-Tween 20 (0.05%) and then 
mounted using the standard protocol.
immunofluorescence – analysis
Fluorescent images were obtained using a “VSlide” slide scan-
ning microscope (MetaSystems, Alltlussheim, Germany). The 
system has a CoolCube 2 camera (12 bit gray scale), a 10× objec-
tive and filter sets for 4′,6-diamidino-2-phenylindole (DAPI) 
(EX350/50–EM470/40), Fluorescein isothiocyanate (FITC) 
(EX493/16−EM527/30), Cyanine (Cy) 3 (EX546/10−EM580/30), 
Cy3.5 (EX581/10−EM617/40), and Cy5 (EX630/20−647/long 
pass). First, the whole brain section was initially pre-scanned at 
2.5× to adjust for focusing and generate a tissue-map. Tissue and 
focus depth were detected based on the DAPI signal. All tissue-
covered areas were scanned using 10× objective. Finally, the indi-
vidual images were stitched together (VSlide) to generate a large 
image of the entire section. After scanning, the images (vsi-files) 
were extracted to high quality Joint Photographic Experts Group 
(jpeg)-files for further analysis using the software Metaviewer® 
(Metasystems, Alltlussheim, Germany). In order to facilitate the 
analysis, the images were downsampled 0.5× to Tagged Image File 
(tif)-files without losing any valuable biological information. An 
example of a scanned slide is available in Supplementary Material.
Quantification of immunofluorescence 
staining
ImageJ was also used to analyze immunoreactivity in the cortical 
tissue surrounding the lesion. A cut-off threshold was chosen 
for each antibody. The threshold varied depending on the signal 
to noise ratio dependent on signal intensity of each antibody in 
order to eliminate potential background noise. A person, blinded 
to oxygenation group and survival time, determined and outlined 
the perilesional area by mapping region of interests (ROIs) in 
ImageJ (Figure 2). These areas were then quantified in ImageJ, 
retaining the “integrated density” of the immunoreactivity (all 
pixels above the specified cut-off threshold), similar to methods 
previously described (62, 63). All available slides were used, 
with a minimum of three sections per brain for each antibody, 
only a few sections did not present with adequate quality and 
where omitted (see Table S1 in Supplementary Material). The set 
antibodies analyzed are illustrated in Figure 3. One rat (ET012, 
hypoxia 7 days) presented as an outlier for all antibody expression 
detected in the immunofluorescence experiments and was thus 
excluded from the study. Since no cavity was found in the sham 
animals, no immunofluorescence was quantified.
neun and DaPi immunofluorescence and 
Measurement of the lesion area
The software ImageJ was used to map the cortical layer devoid 
of NeuN-positive neurons, using the “Polygon selections,” also 
blinded for oxygenation and time after injury (Figure 4). DAPI 
was quantified using a similar approach. For analysis, we used 
at least three sections per brain to detect the largest lesion area, 
maximal area of neuronal loss in the cortex (NeuN), and general 
cellular/tissue loss (DAPI). No cavity was detected in sham ani-
mals and these were thus not included.
statistical analysis
To correlate intra-operative monitored data and post-surgery 
metabolic data, Mann–Whitney U tests were employed to allow 
comparisons between normoxic and hypoxic animals. The MRI 
lesion size was illustrated by using bar plots and compared using a 
Mann–Whitney U test (GraphPad Prism 5.0, GraphPad Software, 
Inc., La Jolla, CA, USA).
A Student’s t-test was applied for S100B data to compare 
hypoxic and normoxic animals on the first day post-TBI as the 
data were normally distributed and this is the only time point were 
S100B could theoretically differ between the two groups since 
its serum half-life has been shown to be as short as 25 min (64).
Magnetic resonance imaging and immunoflourescence out-
comes were assessed with a multiple linear regression model with 
oxygenation state and survival time as independent predictors. 
Oxygenation state (normoxia/hypoxia) was coded as a dummy 
variable. The logarithm of time was used as a continuous vari-
able. This approach was chosen over ANOVA to better account 
for temporal trajectory as well as a global difference over time 
points between oxygenation state. The multiple linear regression 
model was visualized using ggplot2 (65) in R (66). More detailed 
FigUre 3 | immunofluorescence of the analyzed proteins. The image illustrates representative immunofluorescence to the following proteins: (a) HIF-1α (HIF) 
(day 1), (B) VEGF (day 1), (c) C5b-9 (day 1), (D) IgG (day 1), (e) Activated Caspase 3 (day 1), (F) Granulocytes (CD43, day 1), (g) Proliferating microglia (CD34, day 
7), and (h) Macrophages (ED1, day 7) (all red, respectively) at 10× amplification from normoxic animals. NeuN was used to label neurons (green). DAPI was used as 
counterstaining for all cells (blue). All pictures are taken from the peri-lesional area; the cavity is located to the right of each picture. Scale bar = 100 μm.
FigUre 4 | Quantification of cortical neuronal cell death. The section 
was labeled with NeuN (white) and the cortical lesion area (yellow) devoid 
of neurons was measured using the “Free hand” tool in ImageJ. 
Scale bar = 5 mm.
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information on the linear regression models used in this study is 
found in Table S2 in Supplementary Material.
An open Shiny (67) platform including our raw data is pro-
vided, where different analyses may be performed (https://thelin.
shinyapps.io/Hypoxic-TBI-Frontiers).
A p-value <0.05 was considered statistically significant.
resUlTs
Pre-Operative Monitoring and  
Post-surgery Metabolic Data confirm 
a hypoxic status
Physiological data revealed that the hypoxic animals had signifi-
cantly lower oxygen saturation (p < 0.0001), pulse (p = 0.0314), 
and perfusion levels (<0.0001) compared to normoxic rats. 
Analysis of arterial blood samples demonstrated that these 
treatment groups presented significantly different metabolic 
conditions after 30 min of either normoxia or hypoxia. Levels of 
lactate (p < 0.0001), glucose (p = 0.0008), and pH (p = 0.0030) 
were significantly higher in hypoxic compared to normoxic 
animals while pCO2 (p < 0.0001) and pO2 (p < 0.0001) levels 
were significantly lower after hypoxia (Table 2). No difference 
was detected in arterial gas levels of hemoglobin, sodium, and 
potassium (Table  2). Some samples were not analyzed due 
to low blood volumes obtained or other technical difficulties 
(Table 2).
hypoxia enhanced the lesion size and 
neuronal Death after TBi
Examination of T2 MRI scans revealed that hypoxic animals had 
significantly larger lesion volumes compared to normoxic animals 
when later time points were combined for analysis (7, 14, and 
28 days after injury) (p = 0.0173) (Figure 5A). Figure 5B depicts 
two representative brains harvested 28 days post-TBI in normoxic 
(left) and hypoxic (right) rats, with evident, significant difference 
in the lesion size between the two treatments. Figure 5C displays 
the increase of lesion size in hypoxic and normoxic rats measured 
on MRI over 4 weeks. The explanatory R2 containing both oxy-
genation (hypoxia or normoxia) level and survival time was 0.721. 
Moreover, a correlation between higher blood lactate levels and 
increasing area of neuronal death, based on NeuN staining, in all 
animals with lactate levels was detected (p = 0.0012) (Figure 5D). 
Based on NeuN staining, we detected a significantly increased 
rate of neuronal loss in rats exposed to a hypoxic insult compared 
to normoxic animals (p =  0.0316) (Figure  6). Consistent with 
this finding, the lesion size measured in hypoxic animals using 
DAPI staining also increased over time, albeit without reaching 
statistical significance (p = 0.10) (Figure 6).
FigUre 5 | lesion size quantification. (a) illustrates the difference in lesion size between the normoxic (n = 6) and hypoxic group (n = 5) at day 7, 14, and 28 
post-CCI presented as mean and SD. In (B), the lesion size on two representative animals is presented at day 28 following TBI; normoxia (left) and hypoxia (right). 
Scale bar = 5 mm. (c) illustrates changes in lesion size on MRI (y-axis, mm2) over time (x-axis, survival time in days) in hypoxic (red) and normoxic (blue) rats 
(R2 = 0.721). The gray area represents 95% confidence interval while the line is a regression line. (D) Correlations between the neuronal death using tissue area 
devoid of NeuN staining (y-axis, pixels) and all available lactate levels (x-axis, mmol/l) acquired from blood gas post surgery; as lactate increases, so does the lesion 
size (R2 = 0.318).
TaBle 2 | Post- and pre-operative monitoring parameters.
normoxia hypoxia p-Value n
Metabolic parameters (after 30 min normoxia/hypoxia)
Lactate (mmol/L) 1.50 (1.20–1.75) 4.80 (3.38–6.56) <0.0001 21 vs. 26
Glucose (mmol/L) 8.0 (7.0–8.5) 9.6 (8.0–12.0) 0.0008 21 vs. 25
pCO2 (kPa) 4.41 (3.85–5.75) 3.2 (2.57–3.68) <0.0001 21 vs. 24
pO2 (kPa) 15.0 (10.4–17.3) 5.4 (4.9–5.7) <0.0001 17 vs. 20
pH 7.41 (7.36–7.46) 7.49 (7.43–7.54) 0.0030 21 vs. 25
Hemoglobin (g/dL) 125 (116–132) 127 (122–142) 0.3004 12 vs. 19
Na (mmol/L) 142 (139–147) 141 (139–143) 0.4211 21 vs. 26
K (mmol/L) 5.1 (4.0–6.4) 5.7 (4.4–7.9) 0.2223 21 vs. 26
Monitored parameters (during 30 min normoxia/hypoxia)
Saturation (%) 88 (87–90) 57 (55–61) <0.0001 33 vs. 37
Pulse (bpm) 369 (351–399) 389 (365–428) 0.0314 33 vs. 37
Perfusion (rate) 0.18 (0.15–0.25) 0.11 (0.07–0.17) <0.0001 33 vs. 37
Monitored physiological and metabolic parameters in normoxic vs. hypoxic animals. Mann–Whitney U Test was used to perform the statistical analysis. The varying degree of sample 
size was due primarily to loss of blood gas samples (too low levels) or other technical errors with the blood gas device (air bubbles in syringe). Bold indicates significance. Bpm, 
beats per minute.
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cytotoxic and Vascular edema Do not 
Differ in hypoxic and normoxic rats
Based on MRI analysis, we aimed at distinguishing the temporal 
patterns of cytotoxic and vasogenic edema in hypoxic and normoxic 
animal groups (Figure  6). Cytotoxic edema decreased rapidly 
over time while the area obtained for vasogenic edema increased, 
although not significantly. When comparing both treatment groups, 
we found no differences in the extent of either form of brain edema.
FigUre 6 | analyzes of lesion size, edema and immunofluorescence. Lesion size, edema, and immunofluorescence data analysis in hypoxic and normoxic 
rats: (a), Lesion size using DAPI staining, (B) Lesion size using NeuN staining, (c) Cytotoxic edema on MRI, (D) Vasogenic edema on MRI, (e) HIF-1α (HIF), 
(F) C5b-9, (g) Activated caspase-3, (h) CD34, (i) VEGF, (J) IgG, (K) CD43, and (l) ED-1 immunofluorescence intensity. Y-axis represent relative intensity. X-axis 
represents days after injury (log). Blue dots indicate normoxic while red dots represent hypoxic rats; dotted lines delineate regression lines. The gray area 
surrounding each line is the 95% confidence interval. Lesion area using DAPI and NeuN, HIF, C5b-9, Caspase-3, CD34, IgG, and ED1 changed significantly over 
time. Lesion Size, NeuN (p = 0.02), HIF (p = 0.01), and VEGF (p = 0.03) are significantly different between normoxic/hypoxic groups.
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serum levels of s100B Tended to Be 
higher in hypoxic rats at 1 Day Post-TBi
The concentration of S100B in hypoxic animals at 1  day post-
injury was slightly higher when compared to normoxic counter-
part showing a trend toward a significant difference (p = 0.0868) 
(Figure  7). At later time points following TBI, both treatment 
groups failed to show any significant differences in S100B, 
which, however, remained elevated compared to naive animals 
that presented with low S100B levels (median 304 pg/l). Sham 
animals also presented elevated S100B levels, especially hypoxic 
animals 24  h after injury (median 773  pg/l) (data not shown). 
Three animals (two normoxic on day 7 and one hypoxic sham 
on day 1) had levels higher than 5 SD and were excluded from 
the analysis.
hiF-1α and VegF are More elevated in 
normoxic rats
Hypoxia-inducible factor-1 alpha and VEGF expression was 
higher in normoxic animals compared to hypoxic animals, 
especially at the later time points (7, 14, and 28 days) (p < 0.05, 
respectively) (Figure 6). Following an initial upregulation, HIF-
1α decreased significantly over time while VEGF expression 
remained unchanged.
FigUre 7 | serum s100B levels over time after injury. Serum concentration of S100B (y-axis) measured at different times post-CCI (x-axis). Black line indicates 
median naive levels. S100B shows a trend to be significantly elevated in hypoxic compared to normoxic group at 1 day after injury (Student’s t-test p = 0.0868). No 
other survival time showed any significance or trend between groups, yet levels remained elevated compared to naive rats. No significant temporal trend could be 
detected.
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activated caspase 3 and c5b9 expression 
Decreases Over Time but is not 
significantly Different between hypoxic 
and normoxic animals
While activated caspase 3, indicating ongoing apoptosis, was 
higher in the first 3  days after TBI, there was no difference 
between the oxygenation groups or at any time over the 4 weeks. 
C5b9 was found upregulated in the perilesional area, primarily 
in neurons surrounding the contusion. The highest levels were 
seen immediately after trauma and then steadily decreased over 
time (Figure 6). No significant differences were detected between 
oxygenation groups.
immune cell activation is not affected by 
hypoxia
ED1 (predominantly present in macrophages) and CD34 
(predominantly in microglia) expressions were predominantly 
seen in the perilesional subcortical white matter, although also 
spread out over the perilesional cortical areas (Figure 6). CD34 
does not only stain microglia but is also seen in stem cells in 
vascular tissue (displayed as blood vessels); however, microglia-
like morphology was easy to distinguish (58) and was more 
highly expressed than the vasculature. ED1 morphology was 
different than CD34, as is seen in Figure  4, but the antibody 
stains activated microglia as well making it difficult to separate 
the two (and they share expression as is seen in Figure  6). 
CD43 (granulocyte) expression was only detected in cells the 
perilesional area. ED1 and CD34 expression revealed a temporal 
pattern, increasing significantly over time while CD43 remained 
unchanged.
Blood–Brain Barrier Damage increases 
acutely after TBi but is not Different 
between hypoxic and normoxic TBi rats
IgG extravasation, as a sign of BBB disintegration, was evident in 
the perilesional cortex of both oxygenation groups and peaked 
early after injury to then steadily decrease over time. No significant 
difference in the amount of IgG extravasation was found between 
hypoxic and normoxic animals (Figure 6). Notably, the intensity 
of IgG immunoreactivity was highly correlated with complement 
activation based on C5b9 immunofluorescence (R2  =  0.759), 
implying a pathophysiological relationship.
DiscUssiOn
In this study, we demonstrated that a clinically validated post-
traumatic hypoxia paradigm significantly exacerbates the lesion 
size and neuronal loss following CCI in rats. S100B levels in serum 
had a tendency to be higher in hypoxic rats 24 h after trauma. 
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HIF-1α and VEGF immunofluorescence was significantly 
increased only in normoxic but not in hypoxic rats, perhaps 
highlighting their beneficial properties toward surviving neurons 
located in the perilesional area of animals presenting a less severe 
brain damage without hypoxia. To the best of our knowledge, this 
is the first report that investigates how general hypoxia affects the 
inflammatory response in a CCI model.
In our study, a rise in blood lactate levels, as a surrogate marker 
of hypoxia, was significantly correlated to diminished neuronal 
survival. The analysis of lactate levels relative to survival times 
provided a strong (R2 0.47%) explained variance of neuronal 
survival. We believe that lactate is a more reliable indicator of 
hypoxia than pO2 or SO2 since gas changes are more volatile 
and more easily influenced by venous blood contamination. 
Glucose was also significantly higher in the hypoxic rats, perhaps 
as sign of ongoing metabolic distress and subsequent catecho-
lamine surge, both of which have shown to affect outcome in 
TBI patients (68). These metabolic changes are also supported 
by a decrease in perfusion index in hypoxic rats, indicating 
peripheral vasoconstriction. In summary, we demonstrated that 
hypoxia following focal TBI has detrimental effects on neuronal 
survival, being directly correlated to enhanced levels of lactate 
immediately after injury.
Using histopathological examination, other groups have 
shown that the lesion in focal TBI models is amplified follow-
ing hypoxia (17, 45). The loss of cortical neurons was higher in 
hypoxic rats, which is supported by previous findings in a CCI 
model of hypoxic TBI (46). The incidence of neuronal death has 
been shown to increase during the first week following a focal 
hypoxic-TBI, especially in the hippocampus (22, 23, 45, 46, 69), 
likely involving a population of neurons that are more suscepti-
ble to metabolic distress. In our study the lesion area devoid of 
nuclear DAPI signal was not statistically different in hypoxic or 
normoxic animals, but only showed a trend toward larger lesion 
after hypoxia (p = 0.10). However, the lesion area observed with 
DAPI often presented abundant tissue debris in the lesion cavity, 
especially during the early times following CCI; a fact that made it 
unreliable for lesion quantification. Consequently, more empha-
sis was given to lesion measurement using NeuN stained sections. 
While other studies have used MRI to monitor only the extent 
of edema formation acutely following experimental hypoxic-TBI 
(19, 20, 47), in our study, we employed the MRI technology to 
combine measurements of edema with lesion size over 4 weeks 
and demonstrated that the lesion size increased over time, espe-
cially in hypoxic rats. Furthermore, the finding of a larger lesion 
by MRI in hypoxic rats is corroborated by a significantly greater 
contusion size on brain sections stained with NeuN. While early 
after CCI, the core of the lesion becomes necrotic, over time the 
surrounding uninjured tissue will degenerate due to the progres-
sion of edema, activated neurotoxic cascades and cell loss (70). 
In regard to the extent of edema, we did not find a significant 
difference between normoxic and hypoxic rats. This finding is 
similar to a study by a collaborating group that failed to detect any 
significant increase of brain edema in hypoxic TBI rats compared 
to TBI alone (13). Other studies reporting a significant increase 
in edema in hypoxic animals, compared to normoxic, used fluid 
percussion models to inflict TBI (19, 20, 47, 71), which provides 
a more well defined injury area not effected by a lesion cavity, 
presumably better for quantifying edema formation. Both cyto-
toxic and vasogenic edema have been shown play an important 
role if a hypoxic insult is added to brain trauma (18, 20). In CCI 
models, cytotoxic edema has been suggested to be the prominent 
type of edema occurring in the tissue surrounding the lesion (56, 
70) as confirmed in our ex vivo MRI experiments. We observed 
an initial increase of cytotoxic edema followed by a gradual 
decrease; a result in line with previous studies showing low levels 
of cytotoxic edema after 7 days (72, 73). Similar to our findings, 
these reports demonstrated that vasogenic edema was localized 
in close proximity to the lesion (54, 74). The amount of vasogenic 
edema increased over time albeit not significantly, probably due 
to the small sample size of the animal groups. This finding is 
similar to another study of hypoxic TBI that revealed an initial 
increase of cytotoxic edema that switched into vasogenic edema 
later on (47). In conclusion, we report here that rats subjected to 
post-traumatic hypoxia presented significantly increased lesion 
areas using immunohistochemistry and MRI compared to nor-
moxic animals while no significant difference in either cytotoxic 
or vasogenic edema could be detected between the groups using 
our model of focal hypoxic TBI.
The levels of S100B were higher in hypoxic rats 1  day after 
injury, compared to normoxic rats, albeit not reaching significance 
(p = 0.0868). The lack of difference is presumably an effect of low 
power due to a small sample size. For the later survival times, no 
difference between the oxygenation groups was observed, which 
is probably the result of the limited half-life of S100B being as 
short as 25 min in humans (64). Our experience in human studies 
indicates that S100B peaks early after TBI and gradually decreases 
in the acute phase. However, the levels of S100B remained 
increased compared to naive rats, which could be due to ongoing 
gliosis that has been shown to persist for at least 4 weeks following 
TBI (75), which might present both beneficial and detrimental 
effects. Furthermore, on day 1 the hypoxic sham animals had 
similar levels of S100B as the hypoxic TBI animals, suggesting 
that the hypoxia insult alone and the craniotomy are associated 
with increased S100B levels. Osteocytes and dermal cells express 
S100B (76) and could potentially be a source to S100B increases 
early after injury (77). Earlier (presumably only hours after TBI) 
sampling is probably necessary to determine the potential of 
S100B as a biomarker of injury severity. In TBI patients, S100B 
has been shown to correlate to the extent of hypodense lesions 
at hospital admission, perinatal asphyxia as well as subsequent 
ischemic development (40, 42, 78), indicating that if ischemia is 
added to brain injury, it would lead to an additional increase of 
S100B. Altogether, our and other studies support the validity of 
S100B measured early after trauma as a potential biomarker to 
monitoring severe hypoxic injuries following TBI, albeit further 
investigations including earlier survival times are warranted to 
corroborate this assumption.
In our study, we also demonstrated that normoxic animals had 
higher expression of HIF-1α, which was more obvious at later time 
points after CCI (7–14 days). While upregulation of HIF-1α has 
been used to validate hypoxia–ischemic brain injury in neonatal 
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rats (79), HIF-1α has, to our knowledge, never before been used 
to validate hypoxic insults following experimental hypoxic-TBI. 
However, HIF-1α has been previously analyzed under normoxic 
conditions in experimental TBI where it has revealed a temporal 
pattern with an early increase (1 h up to 3 days) followed by a 
later decrease in expression (60, 80, 81), which was correlated 
with the degree of cell apoptosis. In our study, a similar temporal 
pattern of HIF-1α was noted. Previous work has revealed that 
an upregulation of HIF-1α does not necessarily mean that the 
injured tissue will perish. Although it is recognized that HIF-1α 
promotes apoptotic neuronal death (30), it is also known that it 
upregulates angiogenic factors (VEGF), as well as erythropoiesis 
and acts protectively against mitochondrial and cellular damage 
(32, 35, 36, 82). Perhaps in our hypoxic animals, the perilesional 
tissue succumbed rapidly after injury due to necrosis, as sup-
ported by a greater neuronal loss, while in normoxic animals, the 
tissue comprising the penumbra survived, hence being able to 
express HIF-1α. This somewhat paradoxical finding is supported 
by reviews suggesting that in milder hypoxic states, HIF-1α trig-
gers neuro-protective mechanisms, while in more severe hypoxia, 
apoptosis and cellular death often follows HIF-1α activation; thus 
there is a distinction between mild and severe hypoxia induc-
ing protective gene expression mediated by HIF-1α in the first 
instance and apoptotic gene expression in the severe form (30, 
82). In addition, we showed that HIF-1α was strongly correlated 
with VEGF activation (data not shown), as reported earlier (32), 
highlighting the neuro-protective capabilities of HIF-1α. Similar 
to HIF-1α, VEGF expression was found to be upregulated primar-
ily 3, 7, and 14 days following injury, being significantly higher in 
the normoxic group compared to the hypoxic group, yet without 
any significant change over time. Previous studies have shown a 
peak of VEGF expression 4–6 days following TBI (83), whereby 
VEGF seems to act as a promoter of neurogenesis after injury 
(83, 84). By increasing VEGF expression levels, the lesion size 
in experimental TBI has been shown to decrease, supporting its 
neuro-protective role (61). All in all, upregulation of HIF-1α and 
VEGF might reflect the neuro-protective capabilities of surviving 
cells, which could explain their increase following TBI during 
normoxic conditions.
Activated caspase-3 expression, is an indicator of ongoing 
apoptosis, which was elevated primarily in normoxic animals 
early after injury (up to day 3) but then relatively low in both 
hypoxic and normoxic animals. While apoptosis has been primar-
ily identified in hippocampal cell layers following hypoxic TBI (23, 
46), the amount of caspase-3 driven apoptosis in the cortical layers 
has never previously been shown in hypoxic TBI. Similar to other 
protein expressions levels, activated caspase-3 was more elevated 
in normoxic animals, presumably as hypoxic animals suffered 
more of immediate necrosis in the border zone following TBI 
whereas normoxic animals had more neurons that succumbed 
due to apoptosis. Microglia proliferation has been previously 
described in focal TBI within the surrounding contusional areas 
as well as in white matter regions in diffuse TBI (14, 27), with 
a peak after about 7 days and continuing for 4 weeks, similar to 
our findings. Akin to caspase 3-acitivation, pyramidal cell layers 
in cortical and hippocampal neurons appear to be particularly 
vulnerable after injury and hypoxia as microglial proliferation has 
been shown in these regions as well (85). Microglia activation was 
similar in localization and time to macrophage migration was not 
found to be significantly increased in hypoxic animals. The role 
of macrophages recruited to the injured brain has been suggested 
to include phagocytosis of dying cells as well as to remove tissue 
debris resulting from TBI (86). Previous studies have shown that 
macrophages start to migrate and accumulate in the perilesional 
area over 1–4 days after injury reaching a peak at 7 days after focal 
TBI models (27, 87), which was similar in our study. In a diffuse 
model of TBI, adding a similar hypoxic insult resulted in a mac-
rophage infiltration restricted to brain areas with evident axonal 
pathology (corpus callosum, optic tract, and brain stem) being 
highest at 7 and 14 days in both hypoxic and normoxic groups 
(14), with significantly increased infiltration in corpus callosum of 
hypoxic animals. However, the models used are different (diffuse 
vs. CCI) making comparison of such studies difficult. Granulocyte 
accumulation in the perilesional zone, using the marker CD43, 
has been shown to be highest early (1–3 days) after injury (27, 50). 
However, in our model, we did not detect any changes for CD43 
immunoreactivity in the study period, neither did we see any 
significant difference relative to hypoxic and normoxic treatments. 
Altogether, while we did not see a difference in activated caspase-3, 
microglial- (CD34), macrophage- (ED-1), and granulocyte- 
(CD43) infiltration between the different oxygenation states over 
4 weeks, activated caspase-3 was significantly increased early after 
injury while microglia and macrophage activity increased later on.
In a fluid percussion model of focal hypoxic TBI, BBB disinte-
gration has been demonstrated via increased amount of intracer-
ebral IgG (18). In our animals, we saw a peak of IgG extravasation 
early after injury, which is supported by previous reports of 
increased BBB permeability 1–3  days following TBI (88–90). 
Furthermore, IgG auto-antibodies have also been detected, bind-
ing to perilesional neurons following focal TBI, which has been 
suggested to be involved in phagocytosis of these cells (91). In 
line with the edema results from the MRI, which would indicate 
BBB disturbance, we could not detect a greater parenchymal IgG 
immunoreactivity in the hypoxic group. Complement activation 
has been reported to play an important role following TBI (27, 
28, 57), with its upregulation leading to an increase in cellular 
death, primarily involving neurons, in the perilesional area (92). 
To our knowledge, this is the first study to examine complement 
activation and specifically the end-stage product, the membrane 
attack complex C5b-9, in a hypoxic TBI model. We detected 
the same temporal pattern that has been previously described 
for C5b-9 expression (57), being significantly elevated 1–3 days 
compared to 14 and 28 days after CCI, especially in proximity 
of neurons in the perilesional area. However, C5b-9 upregula-
tion did not differ in hypoxic compared to normoxic animals. 
Interestingly, increased C5b-9 correlated to IgG extravasation 
and cytotoxic edema. Previous clinical studies have suggested 
that BBB breakdown and subsequent increased vascular perme-
ability is attributed to complement activation, which is further 
supported by our current findings (93, 94). Perhaps the lack of 
differences is due to the choice of relatively late time points after 
CCI (≥24 h) thus missing the marked disintegration of the BBB, 
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which is known to occur in the early hours following TBI (88). 
In summary, C5b-9 expression and cerebral IgG extravasation 
were not significantly exacerbated or increased in hypoxic TBI 
but were amplified as a result of TBI in normoxic animals.
In summary, while we believe that our choice of CCI as injury 
mechanism better mimics a human focal injury, it is more dif-
ficult to measure the surrounding border zone of injured tissue 
due to the heterogeneous lesion cavity, presumably making other 
methods of more diffuse injury (such as fluid percussion- or dif-
fuse axonal injury models) better to quantify pathophysiology in 
the affected tissue as these will not create widespread necrosis in 
the brain parenchyma. In general, immunohistochemical detec-
tion of a number of factors in the perilesional zone was more 
elevated in normoxic rats compared to hypoxic, which we believe 
is due to a greater extent of surviving tissue in these animals as 
they present with smaller lesion cavities. Moreover, we noted 
that the expression of several tissue proteins and blood S100B 
levels were similar between the groups, which could be the effect 
of too late time-points. We believe this is the case especially for 
S100B, cytotoxic edema, IgG and C5b-9 expression, which should 
probably be measured hours after injury to detect potential differ-
ences between the oxygenation groups. Difficulties also emerges 
when human studies are compared with rodent animal models, 
since rats theoretically have a faster protein metabolism than 
humans and one rat day represents about 90 human days (95, 96). 
However, while this study lacks early time points, it is a unique 
example of well monitored animals with longer survival times, 
followed with MRI examinations up to 4 weeks after injury, indi-
cating a distinct and well-described lesion development and with 
potential neuro-protective mechanisms developing in primarily 
animals that suffer TBI during normoxic conditions.
limitations
In previous studies analyzing protein expression, edema and 
inflammation following experimental hypoxic TBI, a range of 
n =  3 up to n =  10 animals per group has been used (16, 20, 
44–46, 69). We used n =  5 animals per group per time-point 
which we believe is enough to be able to show a difference in 
our immunohistochemistry quantifications, based on previous 
studies. Even if we only performed n = 2 MRI scans per group per 
time-point, due to limited resources, we aggregated the samples 
using our multiple linear regression models for edema (n = 10 
vs. n = 9) and used a Mann–Whitney U test for lesion size (n = 6 
vs. n =  5), hence increasing power. Moreover, we never draw 
any independent conclusions from the MRI analyses, instead we 
combine them with other outcome metrics to tell the full story 
of the pathophysiological mechanism that we believe occurred 
following hypoxic TBI in a CCI model.
Although all animals included in the hypoxic group had lac-
tate levels greater than the normoxic counterparts, the variability 
within the hypoxic group was quite large, indicating that different 
biological responses to a varying degree of pO2 may be possible. 
Moreover, rats with low pCO2 had higher lactate levels, probably 
as a compensatory mechanism (Figure S3 in Supplementary 
Material). Other studies also reported of lower pCO2 in hypoxic-
TBI animals (14, 21, 97), albeit not significantly lower than 
normoxic rats, which could be an effect of lower sample sizes 
compared to this study. However, low pCO2 is presumably occur-
ring in humans suffering from metabolic acidosis due to hypoxia 
post TBI and the corresponding attempt to hyperventilate. This 
could also be an explanation for the paradoxically elevated pH in 
the hypoxic animals. If muscle relaxation had been provided in 
our study, it would perhaps have generated a more homogenous 
hypoxic group as ventilation could be better controlled for. This 
finding further stresses the need for adequate monitoring of 
animals, something which is regrettably lacking in many studies 
of experimental hypoxic-TBI.
Unfortunately, not all rats had blood samples drawn for gas 
analysis after surgery. Low blood volumes, technical difficulties, and 
procedural complications resulted in obtaining blood gas samples 
from 67% of the animals. While this may not a major limitation 
for group comparisons, as the rats without blood drawn presented 
with similar saturation, pulse and perfusion levels as the rats with 
blood gas measurements, we do believe that a larger sample size 
of rats with lactate measurements would have provided a better 
ability to correlate S100B, immunohistochemistry expression, and 
MRI measurements with the severity of the hypoxic event.
Our choice of using immunohistochemistry to quantify the 
expression of different proteins in brain parenchyma is associ-
ated with several limitations. One is that only a two-dimensional 
area is quantified. Western blot still remains a golden standard 
to determine protein expression in experimental TBI experi-
ments. However, it lacks locational and anatomical information 
of protein expression, and several of the quantified proteins are 
expressed in uninjured areas of the brain as well. Our model 
includes only protein expression within the border zone of the 
injury, which is the main ROI in our study. In order to include 
largest lesion volumes, we used several brain sections to find the 
maximal expression, therefore, we believe that we have a more 
reliable measurements of true perilesional protein expression 
compared to Western blot.
As previously discussed, ED-1 could stain both microglia and 
macrophages, and CD34 was not only increased in proliferating 
microglia but also in vascular stem cells. However, through 
morphology, we could detect what we believe represents true 
representations of macrophages and microglia and by using 
adequate cut-off thresholds for quantification, only true expres-
sion was used in the analyses. CD43 is also present in a variety of 
leukocytic cells, perhaps not only indicating granulocyte infiltra-
tion in the perilesional zone but also other cells of hemopoietic 
origin.
All previous experimental studies on post-TBI hypoxia 
included male SD rats, while we used female SD rats. We did not 
aim to analyze pathologic difference between the sexes, but used 
female rats for practical reasons as more easily available in our 
facility. Female sex hormones, especially progesterone, have been 
extensively studied as a neuro-protective agent (98–100). While 
neuronal death (101) and neuroinflammation (102) decreased 
in brain-injured rats treated with progesterone, cytotoxic edema 
was not altered by progesterone therapy (103) In addition, when 
male and female rats are compared, assessing COX-2 response 
in penetrating TBI, differences are small (104). In this context, 
the topic of gender and differences in TBI remains controversial. 
In fact, in human TBI, the female gender seems to be a negative 
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predictor of outcome (105), even if protective effects of the lutheal 
phase in the menstrual cycle have been shown in mild TBI (106). 
Surprisingly, despite the experimental evidence, the beneficial 
properties of progesterone therapy were not substantiated in a 
human clinical trial, ProTECT III that was abandoned due to 
futility (107). Altogether, while the choice of female rats might 
have impaired the opportunity to compare our study to others 
based on male rats, it is difficult to determine to what extent, as 
often similar studies on male rats presented striking differences 
in outcome measures. It is clear that further work is warranted to 
fully elucidate differences between genders in terms of pathologic 
and neurologic outcomes after TBI.
cOnclUsiOn
Our study has shown that adding a hypoxic insult to a model 
of TBI using the CCI paradigm, lead to increased neuronal 
loss and lesion size with a trend toward higher levels of the 
biomarker S100B in serum 1 day after trauma compared to nor-
moxic animals. HIF-1α and VEGF were found more elevated in 
normoxic TBI, primarily at later survival times, perhaps indicat-
ing ongoing neuro-protective mechanisms. Further studies are 
warranted to fully determine the pathophysiological effect of 
hypoxia following TBI.
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